Cloning and Expression of a Fusion Protein Containing Highly Epitopic Regions of Clostridium perfringens Epsilon Toxin and Clostridium novyi Alpha Toxin

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 134

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JCMR-12-2_002

تاریخ نمایه سازی: 22 آذر 1400

چکیده مقاله:

     Clostridium perfringens and novyi species are two important toxin-producing pathogens which pose a risk to the livestock health. Epsilon and alpha toxins are major toxins of these two pathogens, respectively. Advances in current vaccine industrialization lead to the utilization of toxin epitopes instead of the whole pathogen/toxoids to produce novel vaccines. In the present study, bioinformatics approaches were applied to design a fused protein containing both toxin fragments of interest with the highest antigenicity score for B-cells. To do so different specialized algorithms including I-TASSER, IEDB, ElliPro, PyDock and CLC Main Workbench were applied. The chimeric protein was successfully cloned, expressed, and purified using an immobilized-metal affinity chromatography for His-tagged proteins. During in vivo experiments on rabbits, the levels of immunization provided by the recombinant protein or native alpha and epsilon toxins were compared based on serological studies. Results indicated that the designed protein was able to stimulate effective immune responses against both alpha and epsilon toxins. This can be used as a proper strategy to design novel peptide-based subunit vaccines. Clostridium perfringens and novyi species are two important toxin-producing pathogens which pose a risk to the livestock health. Epsilon and alpha toxins are major toxins of these two pathogens, respectively. Advances in current vaccine industrialization lead to the utilization of toxin epitopes instead of the whole pathogen/toxoids to produce novel vaccines. In the present study, bioinformatics approaches were applied to design a fused protein containing both toxin fragments of interest with the highest antigenicity score for B-cells. To do so different specialized algorithms including I-TASSER, IEDB, ElliPro, PyDock and CLC Main Workbench were applied. The chimeric protein was successfully cloned, expressed, and purified using an immobilized-metal affinity chromatography for His-tagged proteins. During in vivo experiments on rabbits, the levels of immunization provided by the recombinant protein or native alpha and epsilon toxins were compared based on serological studies. Results indicated that the designed protein was able to stimulate effective immune responses against both alpha and epsilon toxins. This can be used as a proper strategy to design novel peptide-based subunit vaccines.  

نویسندگان

Mohsen Mehrvarz

Education and Extension Organization (AREEO), Agricultural Research, Razi Vaccine and Serum Research Institute, Mashhad Branch, Mashhad, Iran

Mohsen Fathi Najafi

Education and Extension Organization (AREEO), Agricultural Research, Razi Vaccine and Serum Research Institute, Mashhad Branch, Mashhad, Iran

Taghi Zahraei Salehi

Department of Microbiology and Immunology, Faculty of Veterinary Medicine University of Tehran, Tehran, Iran

Behjat Majidi

Education and Extension Organization (AREEO), Agricultural Research, Razi Vaccine and Serum Research Institute, Mashhad Branch, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Adhikari R. P., Karauzum H., Sarwar J., Abaandou L., Mahmoudieh ...
  • Alves G. G., Machado de Avila R. A., Chavez-Olortegui C. ...
  • Attasi M. Z. (۱۹۸۴) Antigenic structures of proteins: their determination ...
  • Busch C., Schomig K., Hofmann F. and Aktories K. (۲۰۰۰) ...
  • Chandran D., Naidu S. S., Sugumar P., Rani G. S., ...
  • Chen J., Rood J. I. and McClane B. A. (۲۰۱۱) ...
  • Majidi B., Fathi Najafi M. and Saeedyan S. (۲۰۲۰) Expression ...
  • Mehrvarz M., Najafi M. F., Salehi T. Z. and Majidi ...
  • Noshari N. G., Najafi M. F., Kakhki A. m., Majidi ...
  • Oscherwitz J. (۲۰۱۶) The promise and challenge of epitope-focused vaccines. ...
  • Palatnik-de-Sousa C. B., Soares I. d. S. and Rosa D. ...
  • Pilechian L. R., AGHAEI P. K., Shamsara M., Jabbari A., ...
  • Sambrook J., Green M., Sambrook J. and Sambrook J. (۲۰۱۲) ...
  • Schmidt S. R. (۲۰۰۹) Fusion-proteins as biopharmaceuticals–applications and challenges. Curr ...
  • Souza A. M., Reis J. K., Assis R. A., Horta ...
  • Uppalapati S., Kingston J., Murali H. and Batra H. (۲۰۱۲) ...
  • Watts C. (۲۰۰۴) The exogenous pathway for antigen presentation on ...
  • Weimer E. T., Lu H., Kock N. D., Wozniak D. ...
  • نمایش کامل مراجع